{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:31:32Z","timestamp":1790271092412,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"Amyotrophic Lateral Sclerosis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011089","name":"University of Wisconsin Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.00954","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T06:29:52Z","timestamp":1542176992000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Blood Level of Glial Fibrillary Acidic Protein (GFAP) Does not Correlate With Disease Progression in a Rat Model of Familial ALS (SOD1G93A Transgenic)"],"prefix":"10.3389","volume":"9","author":[{"given":"Jeremy","family":"Jeffrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"D'Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1172\/JCI71601","article-title":"Emerging mechanisms of molecular pathology in ALS","volume":"125","author":"Peters","year":"2015","journal-title":"J Clin Invest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbadis.2014.08.010","article-title":"Sporadic and hereditary amyotrophic lateral sclerosis (ALS)","volume":"1852","author":"Ajroud-Driss","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","article-title":"Protein aggregation in amyotrophic lateral sclerosis","volume":"125","author":"Blokhuis","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/187152710791292576","article-title":"Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target","volume":"9","author":"Bogaert","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic Biol Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-2990.2011.01166.x","article-title":"Review: the role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis","volume":"37","author":"Duffy","year":"2011","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2012.10.008","article-title":"Inflammation and neurovascular changes in amyotrophic lateral sclerosis","volume":"53","author":"Evans","year":"2013","journal-title":"Mol Cell Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fncel.2015.00414","article-title":"The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Radford","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(Sici)1098-1136(199807)23:3<249::Aid-Glia7>3.0.Co;2-#","article-title":"Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS","volume":"23","author":"Hall","year":"1998","journal-title":"Glia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/mus.21323","article-title":"Glial fibrillary acidic protein as a marker of axonal damage in chronic neuropathies","volume":"40","author":"Notturno","year":"2009","journal-title":"Muscle Nerve"},{"key":"B12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/mus.20983","article-title":"Glial fibrillary acidic protein: a marker of axonal Guillain-Barre syndrome and outcome","volume":"38","author":"Notturno","year":"2008","journal-title":"Muscle Nerve"},{"key":"B13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.clineuro.2011.11.002","article-title":"Correlational study of the serum levels of the glial fibrillary acidic protein and neurofilament proteins in Parkinson's disease patients","volume":"114","author":"Su","year":"2012","journal-title":"Clin Neurol Neurosurg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1161\/STROKEAHA.117.018409","article-title":"Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage","volume":"48","author":"Katsanos","year":"2017","journal-title":"Stroke"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000142988.49341.D1","article-title":"Neurofilament and glial fibrillary acidic protein in multiple sclerosis","volume":"63","author":"Norgren","year":"2004","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000453460","article-title":"Glial fibrillary acidic protein for prehospital diagnosis of intracerebral hemorrhage","volume":"43","author":"Rozanski","year":"2017","journal-title":"Cerebrovasc Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E823","DOI":"10.1097\/BRS.0000000000000654","article-title":"Diagnostic value of serum levels of GFAP, pNF-H, and NSE compared with clinical findings in severity assessment of human traumatic spinal cord injury","volume":"40","author":"Ahadi","year":"2015","journal-title":"Spine (Phila Pa 1976)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jocn.2015.10.008","article-title":"Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"26","author":"Benninger","year":"2016","journal-title":"J Clin Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neures.2017.09.011","article-title":"The multi-dimensional roles of astrocytes in ALS","volume":"126","author":"Yamanaka","year":"2018","journal-title":"Neurosci Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000089619","article-title":"Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis","volume":"2","author":"Pehar","year":"2005","journal-title":"Neurodegener Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/jnc.12742","article-title":"Enteric GFAP expression and phosphorylation in Parkinson's disease","volume":"130","author":"Clairembault","year":"2014","journal-title":"J Neurochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2016.01.008","article-title":"Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS)","volume":"277","author":"Van","year":"2016","journal-title":"Exp Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/17482960600982447","article-title":"Sexual dimorphism in disease onset and progression of a rat model of ALS","volume":"8","author":"Suzuki","year":"2007","journal-title":"Amyotroph Lateral Scler."},{"key":"B26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3109\/17482968.2012.654393","article-title":"Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis","volume":"13","author":"Hayes-Punzo","year":"2012","journal-title":"Amyotroph Lateral Scler."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.201206-1072OC","article-title":"Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis","volume":"187","author":"Nichols","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2217\/bmm-2018-0149","article-title":"Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2018","journal-title":"Biomark Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"ENEURO.0080-15.2015","DOI":"10.1523\/ENEURO.0080-15.2015","article-title":"CSF and blood levels of GFAP in Alexander disease","volume":"2","author":"Jany","year":"2015","journal-title":"eNeuro"},{"key":"B31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0016-5107(95)70103-6","article-title":"Decrease in a markedly elevated CA19-9 level after stenting of a benign pancreatic ductal stricture","volume":"42","author":"Mauer","year":"1995","journal-title":"Gastrointest Endosc."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00954\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T06:29:54Z","timestamp":1542176994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00954\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":31,"alternative-id":["10.3389\/fneur.2018.00954"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00954","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"article-number":"954"}}